Poland· PL-100075325
Fortrans
A osmotically acting laxatives product containing preparat złożony, registered in Poland by MAYOLY PHARMA FRANCE. The same ATC class is registered in 6 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Preparat złożony is registered in 6 of 19 countries.
Countries holding a registration under ATC A06AD (osmotically acting laxatives), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Preparat złożony · ATC A06AD
6 / 19 countries
- Belgiumprice
- Denmark
- Ireland
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Preparat złożony
- Manufacturer
- MAYOLY PHARMA FRANCE
- Country
- Poland (PL)
- ATC code
- A06AD
- ATC class
- Osmotically acting laxatives
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990708413
- gtin05909990708420
- gtin03582186001493
- gtin03665585003029
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A06AD
Osmotically acting laxatives, as other registers publish it.
- BelgiumCleen Phospho-Soda 240 mg/ml - 542 mg/mlCasen Recordati
- BelgiumColowash 1102 mg - 398 mgLaboratoires Mayoly Spindler
- PolandDuphagolViatris Healthcare Limited
- PolandEziclenMAYOLY PHARMA FRANCE
- PolandFortransDelfarma Sp. z o.o.
- PolandFortransInPharm Sp. z o.o.
- PolandMoviprepDelfarma Sp. z o.o.
- PolandMoviprepNorgine B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d44f1165-63d5-4242-a09c-f762b8979559 GET /v1/drugs/d44f1165-63d5-4242-a09c-f762b8979559?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu doustnego",
"source": "urpl",
"strength": "-",
"packaging": "05909990708413 ¦ Rp ¦ 11350\n4 sasz. 74 g\n05909990708420 ¦ Rp ¦ 19270\n50 sasz. 74 g\n03582186001493 ¦ Rp ¦ Skasowane ¦ 92029\n48 sasz. 74 g\n03665585003029 ¦ Rp ¦ 133876\n48 sasz. 74 g",
"substance": "Natrii hydrogenocarbonas 1.68 mg + Natrii chloridum 1.46 g + Natrii sulfas anhydricus 5.7 g + Kalii chloridum 0.75 g + Macrogolum 64 g",
"common_name": "Preparat złożony",
"pl_product_id": "100075325",
"pozwolenie_nr": "07084",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about preparat złożony.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.